TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24142084

Group type: EXPERIMENTAL
Intervention: Trial-based thought record (TBTR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cognitive therapy (CCT)
Number of subjects: 0
Study: 20606084

Group type: EXPERIMENTAL
Intervention: Imatinib 600 mg/d orally for 7 consecutive days (IM-positive group)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control cohort (IM-negative group)
Number of subjects: 94
Study: 18379217

Group type: EXPERIMENTAL
Intervention: Restriction of blood flow (RBF) group: external compressive force of 200 mm Hg for 5 min followed by 3 min of rest, repeated five times in a single session, two sessions per day for 14 days
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Isometric training (IMT) group: 20 exercises of 5-s isometric contraction of knee extensor, flexor, and ankle plantar flexor muscles, twice a day for 2 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (CON) group: no intervention
Number of subjects: 15
Study: 16761158

Group type: EXPERIMENTAL
Intervention: NSAID (lornoxicam)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Coxib (rofecoxib)
Number of subjects: 122
Study: 14648269

Group type: EXPERIMENTAL
Intervention: Calf-thigh pneumatic compression
Number of subjects: 121

Group type: COMPARATOR
Intervention: Plantar compression
Number of subjects: 121
Study: 10072029

Group type: EXPERIMENTAL
Intervention: nalbuphine 0.08 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: meperidine 0.4 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: saline
Number of subjects: 90
Study: 7673538

Group type: EXPERIMENTAL
Intervention: Autonomic arousal-evoking preexposure film stimulus paired with an erotic stimulus and positive-false VBV feedback
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Neutral-control preexposure film stimulus paired with an erotic stimulus and positive-false VBV feedback
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Autonomic arousal-evoking preexposure film stimulus paired with an erotic stimulus and no feedback
Number of subjects: 64

Group type: COMPARATOR
Intervention: Neutral-control preexposure film stimulus paired with an erotic stimulus and no feedback
Number of subjects: 64
Study: 2174653

Group type: EXPERIMENTAL
Intervention: 1% lignocaine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 1% lignocaine with adrenaline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: pH-adjusted lignocaine solutions (1% lignocaine + 1 ml 8.4% sodium bicarbonate)
Number of subjects: 100

Group type: COMPARATOR
Intervention: plain lignocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: lignocaine with adrenaline
Number of subjects: 100
Study: 6995193

Group type: EXPERIMENTAL
Intervention: Carnidazole (2 g single dose)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Tinidazole (2 g single dose)
Number of subjects: 77
Study: 29450747

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve fermented milk (BFM) - 10 billion bacteria and Lactobacillus acidophilus - 1 billion bacteria, administered one pack per day for 48 weeks
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo, administered one pack per day for 48 weeks
Number of subjects: 195
Study: 27397588

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus acetylsalicylic acid (ASA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) alone
Number of subjects: 0
Study: 25041994

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) treatment, treatment arm 2
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) treatment, treatment arm 1
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) treatment, treatment arm 3
Number of subjects: 745
Study: 22841431

Group type: EXPERIMENTAL
Intervention: Pomade-coated sutures (iodoform + calendula)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Uncoated sutures
Number of subjects: 40
Study: 19952006

Group type: EXPERIMENTAL
Intervention: ST-segment resolution (STD-R) <50%
Number of subjects: 4729

Group type: COMPARATOR
Intervention: ST-segment resolution (STD-R) >=50%
Number of subjects: 4729
Study: 20633465

Group type: EXPERIMENTAL
Intervention: Ephedra sinica (pseudo-ephedrine 31.52 mg)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Evodia rutaecarpa (evodiamine 6.75 mg, rutaecarpine 0.66 mg)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 16846413

Group type: EXPERIMENTAL
Intervention: Shallow technique (ST) with normothermic cardiopulmonary bypass
Number of subjects: 249

Group type: COMPARATOR
Intervention: Iced slush with mild hypothermic cardiopulmonary bypass
Number of subjects: 249
Study: 14693299

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 215

Group type: COMPARATOR
Intervention: Sildenafil 50 mg
Number of subjects: 215
Study: 10574639

Group type: EXPERIMENTAL
Intervention: Increased activated protein C resistance
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Lupus anticoagulant positivity
Number of subjects: 56

Group type: COMPARATOR
Intervention: Reference group (without recurrent abortions)
Number of subjects: 56
Study: 8917240

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hydromorphone
Number of subjects: 10
Study: 1953322

Group type: EXPERIMENTAL
Intervention: Ga‐As + He‐Ne laser treatment
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 58
Study: 6958478

Group type: EXPERIMENTAL
Intervention: Budesonide 200 micrograms twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Beclomethasone 100 micrograms four times daily
Number of subjects: 30
Study: 4032328

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Listening to a story
Number of subjects: 0

Group type: COMPARATOR
Intervention: Division of attention
Number of subjects: 0
Study: 31861349

Group type: EXPERIMENTAL
Intervention: High-catechin group (three daily doses of 57 mg catechins and 100 mg xanthan gum)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Low-catechin group (one daily dose of 57 mg catechins and 100 mg xanthan gum)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo group (0 mg catechins and 100 mg xanthan gum)
Number of subjects: 270
Study: 29903459

Group type: EXPERIMENTAL
Intervention: Single-injection adductor canal block (SACB) with 20 mL of 0.25% bupivacaine, 1.67 mcg/mL of clonidine, 2 mg of dexamethasone, 150 mcg of buprenorphine, and 2.5 mcg/mL of epinephrine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous adductor canal blockade (CACB) with 20 mL of 0.25% bupivacaine and 2.5 mcg/mL of epinephrine followed by an 8 mL/h infusion of 0.125% bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SACB
Number of subjects: 60

Group type: COMPARATOR
Intervention: CACB
Number of subjects: 60
Study: 27124028

Group type: EXPERIMENTAL
Intervention: Sevoflurane (0.5-1.0 vol%) during CPB
Number of subjects: 153

Group type: COMPARATOR
Intervention: Intravenous anesthetics alone (control group)
Number of subjects: 153
Study: 25431346

Group type: EXPERIMENTAL
Intervention: Usual care augmented by virtual house calls with a Parkinson disease specialist
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care in the community
Number of subjects: 200
Study: 22218831

Group type: EXPERIMENTAL
Intervention: Remnant bundle preservation technique (R)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Single-bundle technique (S)
Number of subjects: 136
Study: 19890343

Group type: EXPERIMENTAL
Intervention: No-Sting skin protectant
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Aquaphor
Number of subjects: 69
Study: 18831897

Group type: EXPERIMENTAL
Intervention: Eprosartan (600 mg once daily)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Diltiazem (90 mg twice daily)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Eprosartan
Number of subjects: 53
Study: 16212579

Group type: EXPERIMENTAL
Intervention: Peri-menstrual period
Number of subjects: 20

Group type: COMPARATOR
Intervention: Post-menstrual period
Number of subjects: 20
Study: 12171509

Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated)
Number of subjects: 1690
Study: 10085835

Group type: EXPERIMENTAL
Intervention: Simultaneous injection
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sequential injection
Number of subjects: 46
Study: 7486240

Group type: EXPERIMENTAL
Intervention: Video imaging presentation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard case presentation (CP)
Number of subjects: 74
Study: 2261966

Group type: EXPERIMENTAL
Intervention: 1,000 micrograms.day‐1 beclomethasone dipropionate (BDP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 15 mg.day‐1 oral prednisone (PRD)
Number of subjects: 12
Study: 7376025

Group type: EXPERIMENTAL
Intervention: Peroesophageal injection sclerotherapy using a modified, rigid Negus oesophagoscope under general anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Newer forms of shunts such as the Warren shunt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repeated sclerotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous pitressin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sengstaken tube
Number of subjects: 0
Study: 30988483

Group type: EXPERIMENTAL
Intervention: Information nudge about eligibility for fee waiver
Number of subjects: 933

Group type: COMPARATOR
Intervention: Control group (no information nudge)
Number of subjects: 933
Study: 29889868

Group type: EXPERIMENTAL
Intervention: High salience (pudding) ergogenic placebo supplement
Number of subjects: 34

Group type: COMPARATOR
Intervention: Low salience (capsules) ergogenic placebo supplement
Number of subjects: 34

Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 34
Study: 27151015

Group type: EXPERIMENTAL
Intervention: CIK cell infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: VAD chemotherapy
Number of subjects: 60
Study: 25103167

Group type: EXPERIMENTAL
Intervention: Community-based voluntary counselling and testing for HIV (36 months)
Number of subjects: 56683

Group type: COMPARATOR
Intervention: Standard counselling and testing alone (control group)
Number of subjects: 56683
Study: 22088938

Group type: EXPERIMENTAL
Intervention: BCT (tobacco dependence treatment before CT scan)
Number of subjects: 18

Group type: COMPARATOR
Intervention: ACT (CT scan before tobacco dependence treatment)
Number of subjects: 18
Study: 19773226

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of autologous bone marrow cells (BMCs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no BMC transfer)
Number of subjects: 60
Study: 17635377

Group type: EXPERIMENTAL
Intervention: Lenalidomide 25 mg daily
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Lenalidomide 5 mg daily
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 15088089

Group type: EXPERIMENTAL
Intervention: Diffusion-weighted MR imaging (DWI)
Number of subjects: 268

Group type: COMPARATOR
Intervention: CT imaging
Number of subjects: 268

Group type: COMPARATOR
Intervention: High-resolution MRI
Number of subjects: 268
Study: 10866879

Group type: EXPERIMENTAL
Intervention: Ketorolac (0.5 mg/kg dose-1) IV after surgery and every 6 h for 48 h
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (equivalent volume saline) IV after surgery and every 6 h for 48 h
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9348595

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 28
Study: 8149689

Group type: EXPERIMENTAL
Intervention: Candoxatril (200 mg) given twice daily for 10 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Candoxatril (200 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2943780

Group type: EXPERIMENTAL
Intervention: 3F recanalization catheter (group I)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 4F Grüntzig balloon catheter (group II)
Number of subjects: 162
Study: 31248932

Group type: EXPERIMENTAL
Intervention: Predictive Parenting intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Attention control condition (psychoeducation parent groups)
Number of subjects: 60
Study: 28531312

Group type: EXPERIMENTAL
Intervention: Electromyography (EMG) assessment of facial muscle activity in response to tastants
Number of subjects: 0
Study: 25285987

Group type: EXPERIMENTAL
Intervention: Anodal tDCS of the left temporoparietal area combined with auditory stimulation (broadband noise at tinnitus minimum masking level + 10 dB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham controlled session
Number of subjects: 10
Study: 23727759

Group type: EXPERIMENTAL
Intervention: Whortleberry fruit hydroalcoholic extract (1 capsule = 350 mg, every 8 h for 2 months)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 21502969

Group type: EXPERIMENTAL
Intervention: Combination therapy (dutasteride 0.5 mg plus tamsulosin 0.4 mg)
Number of subjects: 2925

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg
Number of subjects: 2925

Group type: COMPARATOR
Intervention: Dutasteride 0.5 mg
Number of subjects: 2925
Study: 19149835

Group type: EXPERIMENTAL
Intervention: l-cystine and l-theanine
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 16875911

Group type: COMPARATOR
Intervention: Pexelizumab bolus plus infusion (n = 2476)
Number of subjects: 5916

Group type: COMPARATOR
Intervention: Pexelizumab bolus only (n = 937)
Number of subjects: 5916

Group type: COMPARATOR
Intervention: Pexelizumab bolus plus infusion or bolus only (n = 3429)
Number of subjects: 5916
Study: 12776646

Group type: EXPERIMENTAL
Intervention: Tubocurarine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study: 11055473

Group type: EXPERIMENTAL
Intervention: High dietary sodium intake (300 mmol/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Low dietary sodium intake (50 mmol/day)
Number of subjects: 42
Study: 9204060

Group type: EXPERIMENTAL
Intervention: Bath-5-MOP-UVA
Number of subjects: 22

Group type: COMPARATOR
Intervention: Bath-8-MOP-UVA
Number of subjects: 22
Study: 8454143

Group type: COMPARATOR
Intervention: 23-gauge Teflon cannula
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: 23-gauge winged steel needle
Number of subjects: 142
Study: 3756064

Group type: EXPERIMENTAL
Intervention: Salbutamol 10 micrograms min‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Aminophylline 0.2 mg kg‐1 min‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Vasoactive intestinal peptide (VIP) 6 pmol kg‐1 min‐1
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31473512

Group type: EXPERIMENTAL
Intervention: 480 mg choline/day for 12 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 930 mg choline/day for 12 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 2× choline diet in mice
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 4× choline diet in mice
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Genetic variants in CHDH
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Genetic variants in BHMT
Number of subjects: 26
Study: 29712560

Group type: EXPERIMENTAL
Intervention: Continuous care intervention (CCI) including nutritional ketosis
Number of subjects: 349

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 349
Study: 28430318

Group type: EXPERIMENTAL
Intervention: Formal, face-to-face traditional education
Number of subjects: 30

Group type: COMPARATOR
Intervention: Self-directed internet-based education
Number of subjects: 30

Group type: COMPARATOR
Intervention: No education
Number of subjects: 30
Study: 25622594

Group type: EXPERIMENTAL
Intervention: Progressive high-load strength training
Number of subjects: 260

Group type: COMPARATOR
Intervention: General low-load exercises
Number of subjects: 260
Study: 22951087

Group type: EXPERIMENTAL
Intervention: PN-led care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual GP-led care
Number of subjects: 0
Study: 21918168

Group type: EXPERIMENTAL
Intervention: Lidocaine group (2 mL hyperbaric 0.5% bupivacaine plus 0.6 mL 1% lidocaine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (2 mL hyperbaric 0.5% bupivacaine plus 0.6 mL saline)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lidocaine group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 18158291

Group type: EXPERIMENTAL
Intervention: Structured exercise training (SET) programme
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hypocaloric hyperproteic diet
Number of subjects: 40
Study: 17060567

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg once daily (QD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg twice daily (BID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12717126

Group type: EXPERIMENTAL
Intervention: Biphasic shocks
Number of subjects: 91

Group type: COMPARATOR
Intervention: Monophasic shocks
Number of subjects: 91
Study: 10736328

Group type: EXPERIMENTAL
Intervention: Plant stanol esters (0.8 g/d)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Plant stanol esters (1.6 g/d)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Plant stanol esters (2.4 g/d)
Number of subjects: 22
Study: 7924852

Group type: EXPERIMENTAL
Intervention: 1% indomethacin (Indoptic) eye drops
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (10 unaffected children)
Number of subjects: 21
Study: 3073765

Group type: EXPERIMENTAL
Intervention: 30 mg aspirin per day
Number of subjects: 701

Group type: COMPARATOR
Intervention: 1000 mg aspirin per day
Number of subjects: 701
Study: 31749113

Group type: EXPERIMENTAL
Intervention: CKD-11101 (biosimilar of darbepoetin-alfa)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Darbepoetin-alfa
Number of subjects: 403
Study: 29220619

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) group performing a progressive static WBV program after initial training.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group performing no further training after initial training.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Whole-body vibration (WBV) group and Control group.
Number of subjects: 20
Study: 28949898

Group type: EXPERIMENTAL
Intervention: Autonomy-enhanced individualized assent/consent procedure (separated during consent process)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Traditional assent/consent procedure (together during consent process)
Number of subjects: 64
Study: 28703900

Group type: EXPERIMENTAL
Intervention: Rapid genetic counseling and testing (RGCT)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Genetic counseling and testing (GCT)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Referral source
Number of subjects: 265
Study: 24129239

Group type: EXPERIMENTAL
Intervention: Vinflunine
Number of subjects: 357

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 357
Study: 21188596

Group type: EXPERIMENTAL
Intervention: PG102
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 19321052

Group type: EXPERIMENTAL
Intervention: Modified pigtail probes (Group B)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Traditional pigtail probes (Group A)
Number of subjects: 87
Study: 17846266

Group type: EXPERIMENTAL
Intervention: Bilateral acute ventral pallidal stimulation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Bilateral acute dorsal pallidal stimulation
Number of subjects: 22
Study: 15221200

Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11440090

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (BSS), 100 mg/kg/d for 5 days
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (BSS)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451
Study: 9534983

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid biopterin levels
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid NO concentrations
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Macrophage activation markers, neopterin, and sTNFR‐75
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Local Th1 response
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Local production of NO
Number of subjects: 130
Study: 7587909

Group type: EXPERIMENTAL
Intervention: Orthotic device treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 20
Study: 2312473

Group type: EXPERIMENTAL
Intervention: Caffeine (650 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 490883

Group type: EXPERIMENTAL
Intervention: Stepped Care (SC)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Referred Care (RC)
Number of subjects: 4
Study: 31243478

Group type: EXPERIMENTAL
Intervention: Imrecoxib 100 mg
Number of subjects: 24
Study: 28426849

Group type: EXPERIMENTAL
Intervention: Adalimumab (80 mg subcutaneous loading dose followed by 40 mg every other week)
Number of subjects: 443

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 443
Study: 26196078

Group type: EXPERIMENTAL
Intervention: Automated support
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Human support
Number of subjects: 239
Study: 23391776

Group type: EXPERIMENTAL
Intervention: Intravenous antihypertensive treatment targeting systolic BP <150 mm Hg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intravenous antihypertensive treatment targeting systolic BP <180 mm Hg
Number of subjects: 75
Study: 21921208

Group type: EXPERIMENTAL
Intervention: LC16m8
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dryvax
Number of subjects: 0
Study: 19851919

Group type: EXPERIMENTAL
Intervention: Computer skill training and logistic support including a planning workshop for information diffusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Computers only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no full program)
Number of subjects: 0